Amphastar Pharma (AMPH) Tops Q1 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Amphastar Pharmaceuticals Reports Financial Results for the First Quarter Ended March 31, 2016
May 9, 2016 4:07 PM EDTRANCHO CUCAMONGA, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the first quarter ended March 31, 2016.
First Quarter Highlights
Net revenues of $59.4 million for the first quarterGAAP net income of $2.5 million, or $0.05 per diluted share, for the first quarterAdjusted non-GAAP net income of $5.5 million, or $0.12 per diluted share, for the first quarterDr. Jack Zhang, Amphastars CEO, commented:Â We are pleased to announce that we filed... More
